Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumor Cancer × Interleukin-18 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 2 Lymphoma, Non-Hodgkin 2 Solid Tumor Cancer 1 Ovarian, Fallopian Tube and Peritoneal Cancer 1 Ovarian Neoplasms 1 Lymphoma 1

Interventions

ispinesib 2 trametinib 1 irinotecan sucrosofate 1 Vincristine 1 Temozolomide 1 Interleukin-18 1 Immunotherapy 1 Imatinib Mesylate 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00085878 2008-10-16

Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors

GlaxoSmithKline

Phase 1 Completed

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡